AVITA Medical, Inc.
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
RCEL$17.12+3.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
(a) The following exhibits are filed as part of the Quarterly Report on Form 10-Q:
| ExhibitNo. | Description |
| 3.1 | Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the registrant’s Form 8-K12B filed on June 30, 2020) |
| 3.2 | Certificate of Amendment of Certificate of Incorporation (incorporated by reference to Exhibit 3.2 of the registrant’s Form 10-KT filed on February 28, 2022) |
| 3.3 | Amended and Restated Bylaws (incorporated by reference to Exhibit 3.3 of the registrant’s Form 10-KT filed on February 28, 2022) |
| 4.1 | Form of Warrants (included as Annex A to the Fourth Amendment incorporated by reference to Exhibit 10.1 hereto) |
| 10.1 | Fourth Amendment to the Credit Agreement between the Lender and the Company, dated February 13, 2025 (incorporated by reference to Exhibit 10.1 of the registrant’s Form 8-K filed on February 13, 2025) |
| 10.2 | Contract Manufacturing Agreement between the Company and Stedical Scientific, Inc. dated March 17, 2025 (incorporated by reference to Exhibit 10.1 of the registrant’s Form 8-K filed on March 17, 2025) |
| 10.3 | Amendment Two to the Exclusive Distribution Agreement between the Company and Stedical Scientific, Inc. dated March 17, 2025 (incorporated by reference to Exhibit 10.2 of the registrant’s Form 8-K filed on March 17, 2025) |
| 10.4* | Waiver to the Credit Agreement between the Lender and the Company, dated March 31, 2025 |
| 31.1* | Rule 13a-14(a) Certification of Chief Executive Officer |
| 31.2* | Rule 13a-14(a) Certification of Chief Financial Officer |
| 32** | 18 U.S.C. Section 1350 Certifications |
| 101.INS | Inline XBRL Instance Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
† Management contract or compensation plan or arrangement
- Filed herewith
** Furnished herewith
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.